|
1
|
Galoyan A: Neurochemistry of brain
neuroendocrine immune system: Signal molecules. Neurochem Res.
25:9–10. 2000. View Article : Google Scholar
|
|
2
|
Markossian KA, Gurvitz BY and Galoyan AA:
Isolation and chemical identification of new peptides from
neurоsecretory granules of hypothalamus. Neurokhimiya. 16:22–25.
1999.
|
|
3
|
Davtyan TK, Manukyan HA, Mkrtchyan NR,
Avetisyan SA and Galoyan AA: Hypothalamic proline-rich polypeptide
is a regulator of oxidative burst in human neutrophils and
monocyte. Neuroimmunomodulation. 12:270–284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galoyan AA, Sarkissian JS, Sulkhanyan RM,
Chavushyan VA, Avetisyan ZA, Avakyan ZE, Gevorgyan AJ, Abrahamyan
DO and Grigorian YKh: PRP-1 protective effect against central and
peripheral neurodegeneration following n. ischiadicus transection.
Neurochem Res. 30:487–505. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Galoian K, Luo S, Qureshi A, Patel P,
Price R, Morse A, Chailyan G, Abrahamyan S and Temple HT: Proline
rich polypeptide-1 and inflammatory pathway signaling in
chondrosarcoma. Mol Clin Oncol. 5:618–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Durgaryan AA, Matevosyan MB, Seferyan TY,
Sargsyan MA, Grigoryan SL, Galoian KA and Galoyan AA: The
protective and immunomodulatory effects of hypothalamic
proline-rich polypeptide galarmin against methicillin-resistant
Staphylococcus aureus infection in mice. Eur J Clin
Microbiol Infect Dis. 3:2153–2165. 2012. View Article : Google Scholar
|
|
7
|
Galoyan AA, Korochkin LI, Rybalkina EJ,
Pavlova GV, Saburina IN, Zaraiski EI, Galoyan NA, Davtyan TK,
Bezirganyan KB and Revishchin AV: Hypothalamic proline-rich
polypeptide enhances bone marrow colony-forming cell proliferation
and stromal progenitor cell differentiation. Cell Transplant.
17:1061–1066. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galoyan KA, Scully SP and Galoyan AA:
Myc-Oncogene inactivating effect by proline rich polypeptide
(PRP-1) in chondrosarcoma. Neurochem Res. 34:379–385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galoian K, Temple TH and Galoyan A:
Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by
its inhibition of mTOR and cMyc in high grade metastatic
chondrosarcoma. Neurochem Res. 36:812–818. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Galoian KA, Temple HT and Galoyan AA:
Cytostatic effect of novel mTOR inhibitor, PRP-1 in MDA231 (ER-)
breast carcinoma cell line. The cytokine inhibits mesenchymal
tumors. Tumor Biol. 32:745–751. 2011. View Article : Google Scholar
|
|
11
|
Galoian KA, Guettouche T, Issac B, Qureshi
A and Temple HT: Regulation of onco and tumor suppressor miRNAs by
mTORC1 inhibitor PRP-1 in human chondrosarcoma. Tumour Biol.
35:2335–2341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galoian K, Qureshi A, Dippolito G,
Schiller PC, Molinari M, Johnstone AL, Brothers SP, Paz AC and
Temple HT: Epigenetic regulation of embryonic stem cell marker
miR302C in human chondrosarcoma as determinant of antiproliferative
activity of proline rich polypeptide-1. Lnt J Oncol. 47:465–472.
2015. View Article : Google Scholar
|
|
13
|
Galoian K, Qureshi A, Wideroff G and
Temple HT: Restoration of desmosomal junction protein expression
and inhibition of H3K9-specific histone demethylase activity by
cytostatic proline-rich polypeptide-1 leads to suppression of
tumorigenic potential in human chondrosarcoma cells. Mol Clin
Oncol. 3:171–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chailakhyan RK, Gerasimov YV, Chailakhyan
MR and Galoyan AA: Proline-rich hypothalamic polypeptide has
opposite effects on the proliferation of human normal bone marrow
stromal cells and human giant-cell tumour stromal cells. Neurochem
Res. 35:934–939. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Galoian K, Abrahamyan S, Chailyan G,
Qureshi A, Patel P, Metser G, Moran A, Sahakyan I, Tumasyan N, Lee
A, et al: Toll like receptors TLR1/2, TLR6 and MUC5B as binding
interaction partners with cytostatic proline rich polypeptide 1 in
human chondrosarcoma. Int J Oncol. 52:139–154. 2018.PubMed/NCBI
|
|
16
|
Galoian K, Scully S, McNamara G, Flynn P
and Galoyan A: Antitumorigenic effect of brain proline rich
polypeptide-1 in human chondrosarcoma. Neurochem Res. 34:2117–2121.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jaganathan SK, Mondhe D, Wani ZA, Pal HC
and Mandal M: Effect of honey and eugenol on Ehrlich ascites and
solid carcinoma. J Biomed Biotechnol. 9891632010.PubMed/NCBI
|
|
18
|
Frajacomo FT, de Souza Padilha C,
Marinello PC, Guarnier FA, Cecchini R, Duarte JA and Deminice R:
Solid Ehrlich carcinoma reproduces functional and biological
characteristics of cancer cachexia. Life Sci. 162:47–53. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mondal A, Singha T, Maity TK and Pal D:
Evaluation of antitumor and antioxidant activity of
melothriaheterophylla (Lour.). Cogn. Indian J Pharm Sci.
75:515–522. 2013.PubMed/NCBI
|
|
20
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol. 111:A3B1–A3B3. 2015.
View Article : Google Scholar
|
|
21
|
Fischer A, Jacobson KA, Rose J and Zeller
R: Hematoxylin and eosin staining of tissue and cell sections. CSH
Protoc pdb.prot4986. 2008.
|
|
22
|
Redginal H: Giemsa preparation for
staining blood films. Science. 86:5481937. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deshpande AK, Bayya P and Veeragandham S:
Comparative study of Papanicolaou stain (PAP) with rapid economic
acetic acid papanicolaou stain (REAP) in cervical cytology. J
Evolution of Med Dental Sci. 4:7089–7095. 2015. View Article : Google Scholar
|
|
24
|
Farinacci M: Improved apoptosis detection
in ovine neutrophils by annexin V and carboxyfluorescein diacetate
staining. Cytotechnology. 54:149–155. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szkaradek N, Sypniewski D, Waszkielewicz
AM, Gunia-Krzyżak A, Galilejczyk A, Gałka S, Marona H and Bednarek
I: Synthesis and in vitro evaluation of the anticancer potential of
new aminoalkanol derivatives of xanthone. Anticancer Agents Med
Chem. 16:1587–1604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu SM, Roine L and Farger H: Use of
avidin-biotin-peroxidasee (ABC) in immunoperoxidase technioques:
comparison between ABC and unlabelled antibody (PAP) procedures. J
Histochem Cytochem. 29:577–580. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ambrosius X: Obtaining of antisera from
different animals. Immunological methods. Frimel HG: pp. 14–15.
1987
|
|
28
|
Bret-Dibat JL, Zouaoui D, Déry O, Zerari
F, Grassi J, Maillet S, Conrath M and Couraud JY: Antipeptide
polyclonal antibodies that recognize a substance P-binding site in
mammalian tissues: A biochemical and immunocytochemical study. J
Neurochem. 63:333–343. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Engvall E: Enzyme immunoassay ELISA and
EMIT. Methods Enzymol. 70:419–439. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kasper DL and Zaleznik DF: Gas gangrene,
antibiotic associated colitis, and other Clostridial infections. In
Stone RM. Harrison's principles of internal medicine
self-assessment and board review. Med Pub Div. 922–927. 2001.
|
|
31
|
Andrade R, Crisol L, Prado R, Boyano MD,
Arluzea J and Arechaga J: Plasma membrane and nuclear envelope
integrity during the blebbing stage of apoptosis: A time-lapse
study. Biol Cell. 102:25–35. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shimizu T, Maeno E and Okada Y:
Prerequisite role of persistent cell shrinkage in apoptosis of
human epithelial cells. Sheng Li Xue Bao. 59:512–516.
2007.PubMed/NCBI
|
|
33
|
Somasekharan SP, Koc M, Morizot A, Micheau
O, Sorensen PH, Gaide O, Andera L and Martinou JC: TRAIL promotes
membrane blebbing, detachment and migration of cells displaying a
dysfunctional intrinsic pathway of apoptosis. Apoptosis.
18:324–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nagata S: Apoptotic DNA fragmentation. Exp
Cell Res. 256:12–18. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nagata S, Nagase H, Kawane K, Mukae N and
Fukuyama H: Degradation of chromosomal DNA during apoptosis. Cell
Death Differ. 10:108–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fadok VA, Bratton DL and Henson PM:
Phagocyte receptors for apoptotic cells: Recognition, uptake and
consequences. J Clin Invest. 108:957–962. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Henson PM, Bratton DL and Fadok VA:
Apoptotic cell removal. Curr Biol. 11:R795–R805. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shacter E, Williams JA, Hinson RM,
Senturker S and Lee YJ: Oxidative stress interferes with cancer
chemotherapy: Inhibition of lymphoma cell apoptosis and
phagocytosis. Blood. 96:307–313. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Niles AL, Moravec RA and Riss TL: In vitro
viability and cytotoxicity testing and same-well multi-parametric
combinations for high throughput screening. Curr Chem Genomics.
3:33–41. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Proskuryakov SY, Konoplyannikov AG and
Gabai VL: Necrosis: A specific form of programmed cell death? Exp
Cell Res. 283:1–16. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kroemer G, Galluzzi L, Vandenabeele P,
Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS,
Golstein P, Green DR, et al: Classification of cell death:
Recommendations of the nomenclature committee on cell death. Cell
Death Differ. 16:3–11. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tumasyan N, Sahakyan I, Kocharyan N,
Galoyan K and Abrahamyan S: Effect of the physiologically active
compounds on rat brain plasticity under the stress. Materials of
the XIV International scientific ecological. Conference. 240–242.
2016.
|
|
43
|
Abrahamyan SS, Meliksetyan IB, Chavushyan
VA, Aloyan ML and Sarkissian JS: Protective action of snake venom
Naja Naja Oxiana at spinal cord hemisection. Ideggyogy Sz.
60:148–153. 2007.PubMed/NCBI
|
|
44
|
Abrahamyan SS, Sahakyan IK, Meliksetyan
IB, Tumasyan NV, Badalyan BY and Galoyan AA: Histochemical and
immunohistochemical study of morphofunctional state of brain and
bone marrow cell structures of rats under stress. N Armenian Med J.
5:60–68. 2011.
|
|
45
|
Abrahamyan SS, Davtyan TK, Khachatryan AR,
Tumasyan NV, Sahakyan IK, Harutyunyan HA, Chailyan SG and Galoyan
AA: Quantification of the hypothalamic proline rich polypeptide-1
in rat blood serum. Neirokhimiya. 31:47–53. 2014.
|
|
46
|
Antonyan АA, Sharoyan SG, Mardanyan SS and
Galoyan AA: Proline-rich cytokine from neurosecretory granules: A
new natural substrate for dipeptidyl peptidase IV. Neurochem Res.
36:34–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mentlein R: Proline residues in the
maturation and degradation of peptide hormones and neuropeptides.
FEBS Lett. 234:251–256. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yaron A and Naider F: Proline-dependent
structural and biological properties of peptides and proteins. Crit
Rev Biochem Mol Biol. 28:31–81. 1993. View Article : Google Scholar : PubMed/NCBI
|
